Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.46 USD | -0.67% | -2.62% | -49.60% |
May. 21 | Palisade Bio, Inc. Announces Presentation of Positive Preclinical Data from PALI-2108 | CI |
May. 13 | Palisade Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.2M |
---|---|---|---|---|---|
Net income 2024 * | -14M | Net income 2025 * | -19M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.39
x | P/E ratio 2025 * |
-0.51
x | Employees | 9 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.9% |
1 day | -2.60% | ||
1 week | +1.58% | ||
Current month | -6.85% | ||
1 month | -33.08% | ||
3 months | -23.79% | ||
6 months | -50.75% | ||
Current year | -49.27% |
Managers | Title | Age | Since |
---|---|---|---|
J. D. Finley
CEO | Chief Executive Officer | 66 | 21-04-26 |
Nicholas McCoy
CTO | Chief Tech/Sci/R&D Officer | - | - |
Mitchell Jones
CTO | Chief Tech/Sci/R&D Officer | 46 | 23-09-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Williams
CHM | Chairman | 65 | 21-04-26 |
J. D. Finley
CEO | Chief Executive Officer | 66 | 21-04-26 |
Bin Xian Wei
BRD | Director/Board Member | 54 | 18-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-12 | 4.46 | -0.67% | 15 946 |
24-06-11 | 4.49 | -2.60% | 34,171 |
24-06-10 | 4.61 | +0.88% | 15,026 |
24-06-07 | 4.57 | -2.56% | 7,203 |
24-06-06 | 4.69 | +2.40% | 38,598 |
Delayed Quote Nasdaq, June 11, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.27% | 4.2M | |
+49.21% | 56.87B | |
+34.49% | 39.72B | |
-6.86% | 39.27B | |
-4.42% | 28.73B | |
+12.00% | 26.21B | |
-18.27% | 19.79B | |
+29.57% | 12.28B | |
+25.41% | 12.23B | |
-0.35% | 12.12B |
- Stock Market
- Equities
- SNCA Stock